DSC: Exploring the Safety and Efficacy of Everolimus in PTEN Hamartoma Tumor Syndrome
7 nov 2022 ·
2 min. 1 sec.
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
New research from the Developmental Synaptopathies Consortium (DSC). This summary is based on a paper published in the journal Human Molecular Genetics on October 15, 2022, titled "A randomized controlled...
mostra di più
New research from the Developmental Synaptopathies Consortium (DSC). This summary is based on a paper published in the journal Human Molecular Genetics on October 15, 2022, titled "A randomized controlled trial of everolimus for neurocognitive symptoms in PTEN hamartoma tumor syndrome."
Read the paper here: https://academic.oup.com/hmg/article/31/20/3393/6589680
Learn more about DSC: https://www1.rarediseasesnetwork.org/cms/dsc
mostra meno
Read the paper here: https://academic.oup.com/hmg/article/31/20/3393/6589680
Learn more about DSC: https://www1.rarediseasesnetwork.org/cms/dsc
Informazioni
| Autore | RDCRN |
| Sito | - |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
